Movatterモバイル変換


[0]ホーム

URL:


US20100047915A1 - Identifying patients at risk for life threatening arrhythmias - Google Patents

Identifying patients at risk for life threatening arrhythmias
Download PDF

Info

Publication number
US20100047915A1
US20100047915A1US12/606,173US60617309AUS2010047915A1US 20100047915 A1US20100047915 A1US 20100047915A1US 60617309 AUS60617309 AUS 60617309AUS 2010047915 A1US2010047915 A1US 2010047915A1
Authority
US
United States
Prior art keywords
patient
risk
assessing
patients
measurement
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US12/606,173
Inventor
Orhan Soykan
Amy C. Dearking
Timothy H. Robinson
Walter H. Olson
Vinod Sharma
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Medtronic Inc
Original Assignee
Medtronic Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US11/050,611external-prioritypatent/US7622303B2/en
Application filed by Medtronic IncfiledCriticalMedtronic Inc
Priority to US12/606,173priorityCriticalpatent/US20100047915A1/en
Publication of US20100047915A1publicationCriticalpatent/US20100047915A1/en
Abandonedlegal-statusCriticalCurrent

Links

Images

Classifications

Definitions

Landscapes

Abstract

The invention is a method for identifying proteins associated with sudden cardiac death (SCD) and for assessing a patient's risk of SCD by determining the amount of one or more SCD-associated proteins in the patient. Typically, the patient submits a sample, such as a blood sample, which is tested for one or more SCD-associated proteins. Based upon the results of the tests, the patient's risk of SCD may be assessed.

Description

Claims (21)

US12/606,1732004-02-052009-10-26Identifying patients at risk for life threatening arrhythmiasAbandonedUS20100047915A1 (en)

Priority Applications (1)

Application NumberPriority DateFiling DateTitle
US12/606,173US20100047915A1 (en)2004-02-052009-10-26Identifying patients at risk for life threatening arrhythmias

Applications Claiming Priority (4)

Application NumberPriority DateFiling DateTitle
US54200404P2004-02-052004-02-05
US11/050,611US7622303B2 (en)2004-02-052005-02-03Methods for identifying patients at risk for life threatening arrhythmias
US11/157,549US7608458B2 (en)2004-02-052005-06-21Identifying patients at risk for life threatening arrhythmias
US12/606,173US20100047915A1 (en)2004-02-052009-10-26Identifying patients at risk for life threatening arrhythmias

Related Parent Applications (1)

Application NumberTitlePriority DateFiling Date
US11/157,549ContinuationUS7608458B2 (en)2004-02-052005-06-21Identifying patients at risk for life threatening arrhythmias

Publications (1)

Publication NumberPublication Date
US20100047915A1true US20100047915A1 (en)2010-02-25

Family

ID=46123905

Family Applications (2)

Application NumberTitlePriority DateFiling Date
US11/157,549Expired - Fee RelatedUS7608458B2 (en)2004-02-052005-06-21Identifying patients at risk for life threatening arrhythmias
US12/606,173AbandonedUS20100047915A1 (en)2004-02-052009-10-26Identifying patients at risk for life threatening arrhythmias

Family Applications Before (1)

Application NumberTitlePriority DateFiling Date
US11/157,549Expired - Fee RelatedUS7608458B2 (en)2004-02-052005-06-21Identifying patients at risk for life threatening arrhythmias

Country Status (1)

CountryLink
US (2)US7608458B2 (en)

Cited By (10)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
US20090099611A1 (en)*2006-11-302009-04-16Sigg Daniel CBiological pacemakers including mutated hyperpolarization-activated cyclic nucleotide-gated (hcn) channels
US20110144028A1 (en)*2009-12-112011-06-16Vinod SharmaModulating cellular electrophysiology
US8639323B2 (en)2010-11-012014-01-28Medtronic, Inc.System and apparatus to monitor biopacemaker maturation
US10016600B2 (en)2013-05-302018-07-10Neurostim Solutions, LlcTopical neurological stimulation
US10953225B2 (en)2017-11-072021-03-23Neurostim Oab, Inc.Non-invasive nerve activator with adaptive circuit
US11077301B2 (en)2015-02-212021-08-03NeurostimOAB, Inc.Topical nerve stimulator and sensor for bladder control
US11229789B2 (en)2013-05-302022-01-25Neurostim Oab, Inc.Neuro activator with controller
US11312994B2 (en)2014-05-052022-04-26Medtronic, IncMethods and compositions for SCD, CRT, CRT-D, or SCA therapy identification and/or selection
US11458311B2 (en)2019-06-262022-10-04Neurostim Technologies LlcNon-invasive nerve activator patch with adaptive circuit
US11730958B2 (en)2019-12-162023-08-22Neurostim Solutions, LlcNon-invasive nerve activator with boosted charge delivery

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
US7608458B2 (en)*2004-02-052009-10-27Medtronic, Inc.Identifying patients at risk for life threatening arrhythmias
US8027791B2 (en)2004-06-232011-09-27Medtronic, Inc.Self-improving classification system
US20050287574A1 (en)*2004-06-232005-12-29Medtronic, Inc.Genetic diagnostic method for SCD risk stratification
US8335652B2 (en)*2004-06-232012-12-18Yougene Corp.Self-improving identification method
US20110143956A1 (en)*2007-11-142011-06-16Medtronic, Inc.Diagnostic Kits and Methods for SCD or SCA Therapy Selection
EP2222877A4 (en)*2007-11-142011-10-12Medtronic IncGenetic markers for scd or sca therapy selection
EP3536376A1 (en)2008-07-302019-09-11Ecole Polytechnique Fédérale de LausanneApparatus for optimized stimulation of a neurological target
WO2010046321A1 (en)*2008-10-202010-04-29Nestec S.A.Nutritional composition with anti-regurgitation properties
EP3231476B1 (en)2008-11-122019-06-19Ecole Polytechnique Fédérale de LausanneMicrofabricated neurostimulation device
WO2010132546A2 (en)*2009-05-122010-11-18Medtronic, Inc.Sca risk stratification by predicting patient response to anti-arrhythmics
AU2010326613B2 (en)2009-12-012015-09-17Ecole Polytechnique Federale De LausanneMicrofabricated surface neurostimulation device and methods of making and using the same
US8529448B2 (en)2009-12-312013-09-10Cerner Innovation, Inc.Computerized systems and methods for stability—theoretic prediction and prevention of falls
WO2011121089A1 (en)2010-04-012011-10-06Ecole Polytechnique Federale De Lausanne (Epfl)Device for interacting with neurological tissue and methods of making and using the same
US9132275B2 (en)2010-11-182015-09-15Cardiac Pacemakers, Inc.Automatic determination of chronotropic incompetence using atrial pacing at rest
US11311718B2 (en)2014-05-162022-04-26Aleva Neurotherapeutics SaDevice for interacting with neurological tissue and methods of making and using the same
US10966620B2 (en)2014-05-162021-04-06Aleva Neurotherapeutics SaDevice for interacting with neurological tissue and methods of making and using the same
US9474894B2 (en)2014-08-272016-10-25Aleva NeurotherapeuticsDeep brain stimulation lead
US9403011B2 (en)2014-08-272016-08-02Aleva NeurotherapeuticsLeadless neurostimulator
WO2017134587A1 (en)2016-02-022017-08-10Aleva Neurotherapeutics, SaTreatment of autoimmune diseases with deep brain stimulation
AU2018324195B2 (en)2017-09-012024-12-12Venn Biosciences CorporationIdentification and use of glycopeptides as biomarkers for diagnosis and treatment monitoring
US10702692B2 (en)2018-03-022020-07-07Aleva NeurotherapeuticsNeurostimulation device

Citations (29)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
US5474796A (en)*1991-09-041995-12-12Protogene Laboratories, Inc.Method and apparatus for conducting an array of chemical reactions on a support surface
US20010053519A1 (en)*1990-12-062001-12-20Fodor Stephen P.A.Oligonucleotides
US20020076809A1 (en)*2000-03-212002-06-20Klaus SteinmeyerPotassium channel protein KCNQ5, a new target for diseases of central nervous system and cardiovascular system
US6458542B1 (en)*1999-10-082002-10-01Vanderbilt UniversityMethod of screening for susceptibility to drug-induced cardiac arrhythmia
US20020155539A1 (en)*1999-07-282002-10-24Human Genome Sciences, Inc.Calcium channel polynucleotides, polypeptides, and antibodies
US20020165161A1 (en)*2001-05-042002-11-07Surromed, Inc.Chemokine-binding proteins for treating congestive heart failure
US6500630B2 (en)*2001-01-122002-12-31Mayo Foundation For Medical Education And ResearchMarker for inflammatory conditions
US20030092019A1 (en)*2001-01-092003-05-15Millennium Pharmaceuticals, Inc.Methods and compositions for diagnosing and treating neuropsychiatric disorders such as schizophrenia
US20040029259A1 (en)*2002-04-262004-02-12Mcdevitt John T.Method and system for the detection of cardiac risk factors
US20040058388A1 (en)*2002-07-292004-03-25Hitt Ben A.Quality assurance/quality control for high throughput bioassay process
US6727063B1 (en)*1999-09-102004-04-27Millennium Pharmaceuticals, Inc.Single nucleotide polymorphisms in genes
US20050053956A1 (en)*2002-11-132005-03-10Dietz Harry C.Detection of a predisposition for the development of coronary artery disease
US20050142591A1 (en)*2003-10-292005-06-30Ackerman Michael J.Method of genetic testing in heritable arrhythmia syndrome patients
US20050177196A1 (en)*2004-02-052005-08-11Orhan SoykanMethods and apparatus for identifying patients at risk for life threatening arrhythmias
US20050181386A1 (en)*2003-09-232005-08-18Cornelius DiamondDiagnostic markers of cardiovascular illness and methods of use thereof
US20050266576A1 (en)*2004-02-052005-12-01Medtronic, Inc.Identifying patients at risk for life threatening arrhythmias
US20060024715A1 (en)*2004-07-022006-02-02Affymetrix, Inc.Methods for genotyping polymorphisms in humans
US20060063162A1 (en)*2004-09-232006-03-23Deng David XBiological marker for inflammation
US20060147450A1 (en)*2002-10-042006-07-06Shelton David LMethods for treating cardiac arrhythmia and preventing death due to cardiac arrhythmia using ngf antagonists
US20070026393A1 (en)*2000-04-062007-02-01Kurt BerlinDetection of variations in the dna methylation profile
US20070038386A1 (en)*2003-08-052007-02-15Schadt Eric EComputer systems and methods for inferring casuality from cellular constituent abundance data
US20070042382A1 (en)*2003-03-102007-02-22Applera CorporationGenetic polymorphisms associated with myocardial infarction, methods of detection and uses thereof
US20070054278A1 (en)*2003-11-182007-03-08Applera CorporationPolymorphisms in nucleic acid molecules encoding human enzyme proteins, methods of detection and uses thereof
US20070065865A1 (en)*2005-09-082007-03-22Affymetrix, Inc.Polymorphisms Associated with Coronary Artery Disease
US20070082347A1 (en)*2005-06-082007-04-12Myriad Genetics, IncorporatedGene variants and use thereof
US20070141570A1 (en)*2003-03-072007-06-21Sequenom, Inc.Association of polymorphic kinase anchor proteins with cardiac phenotypes and related methods
US20090136954A1 (en)*2007-11-142009-05-28Medtronic, Inc.Genetic markers for scd or sca therapy selection
US20100021903A1 (en)*2006-11-152010-01-28University Of Florida Research Foundation, Inc.Use of Genetic Determinants in Cardiovascular Risk Assessment
US8027791B2 (en)*2004-06-232011-09-27Medtronic, Inc.Self-improving classification system

Family Cites Families (37)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
US5018067A (en)1987-01-121991-05-21Iameter IncorporatedApparatus and method for improved estimation of health resource consumption through use of diagnostic and/or procedure grouping and severity of illness indicators
US5437285A (en)1991-02-201995-08-01Georgetown UniversityMethod and apparatus for prediction of sudden cardiac death by simultaneous assessment of autonomic function and cardiac electrical stability
US5199428A (en)1991-03-221993-04-06Medtronic, Inc.Implantable electrical nerve stimulator/pacemaker with ischemia for decreasing cardiac workload
US6021345A (en)1991-05-172000-02-01Cedars-Sinai Medical CenterMethods for detecting propensity for fibrillation using an electrical restitution curve
WO1996012187A1 (en)1994-10-131996-04-25Horus Therapeutics, Inc.Computer assisted methods for diagnosing diseases
EP0815197B1 (en)1995-03-092006-01-18University Of Utah Research FoundationLong qt genes and method for diagnosing or preventing the occurrence of long qt syndrome
DK0842475T3 (en)1995-07-252000-11-27Horus Therapeutics Inc Computer-aided methods and apparatus for diagnosing diseases
US6274332B1 (en)1995-12-222001-08-14Univ. Of Utah Research FoundationMutations in the KCNE1 gene encoding human minK which cause arrhythmia susceptibility thereby establishing KCNE1 as an LQT gene
CA2247800A1 (en)1997-03-271998-10-01Smithkline Beecham Laboratoires PharmaceutiquesNovel compounds
US6221586B1 (en)1997-04-092001-04-24California Institute Of TechnologyElectrochemical sensor using intercalative, redox-active moieties
US6210976B1 (en)1997-06-102001-04-03Medlyte Diagnostics, Inc.Methods for early detection of heart disease
US6197503B1 (en)1997-11-262001-03-06Ut-Battelle, LlcIntegrated circuit biochip microsystem containing lens
US6099469A (en)1998-06-022000-08-08Armstrong; E. GlennReflex algorithm for early and cost effective diagnosis of myocardial infractions suitable for automated diagnostic platforms
GB2339200B (en)1998-06-062001-09-12Genostic Pharma LtdGenostics
AU4833899A (en)1998-06-242000-01-10Therasense, Inc.Multi-sensor array for electrochemical recognition of nucleotide sequences and methods
EP1112362B1 (en)1998-09-102006-02-08Siffert, WinfriedGENE MODIFICATION IN THE GENE FOR THE DIE G$g(b)3-SUB-UNIT OF HUMAN G-PROTEIN
US6647341B1 (en)1999-04-092003-11-11Whitehead Institute For Biomedical ResearchMethods for classifying samples and ascertaining previously unknown classes
US20020077470A1 (en)1999-04-262002-06-20Walker Michael G.Cardiac muscle-associated genes
US20030228565A1 (en)2000-04-262003-12-11Cytokinetics, Inc.Method and apparatus for predictive cellular bioinformatics
US6233487B1 (en)1999-06-082001-05-15Impulse Dynamics N.V.Apparatus and method for setting the parameters of an alert window used for timing the delivery of ETC signals to a heart under varying cardiac conditions
US20020182599A1 (en)2000-01-122002-12-05Fishman Mark CMethods for diagnosing and treating heart disease
DE10007715A1 (en)2000-02-192001-08-23Biotronik Mess & Therapieg Medical therapy device and sensor for obtaining molecular genetic information for the device
US20020049772A1 (en)2000-05-262002-04-25Hugh RienhoffComputer program product for genetically characterizing an individual for evaluation using genetic and phenotypic variation over a wide area network
CA2410949A1 (en)2000-05-302001-12-06Medigene AgNovel target genes for diseases of the heart
EP1176197A1 (en)2000-06-162002-01-30Vlaams Interuniversitair Instituut voor Biotechnologie vzw.A transgenic animal model for cardiac arrhythmias
US20020059030A1 (en)2000-07-172002-05-16Otworth Michael J.Method and apparatus for the processing of remotely collected electronic information characterizing properties of biological entities
EA200300161A1 (en)2000-07-182003-12-25Коррелоджик Системз, Инк. METHOD OF RECOGNITION OF BIOLOGICAL CONDITIONS BASED ON HIDDEN PARAMETERS OF BIOLOGICAL DATA
AU2001276976A1 (en)2000-07-202002-02-05University Of Utah Research FoundationCommon polymorphism in scn5a implicated in drug-induced cardiac arrhythmia
US6811993B2 (en)2000-12-222004-11-02Joslin Diabetes Center, Inc.Diagnostic and screening methods based on monocyte PKC activity
US20020115073A1 (en)2001-02-162002-08-22Nickolas PapadopoulosGenome-based personalized medicine
AU2002258922A1 (en)2001-04-242002-11-05University Of Utah Research FoundationMethod for assessing risk for cardiac dysrhythmia in a human subject
US20030003588A1 (en)2001-06-282003-01-02Comper Wayne D.Method for kidney disease detection by protein profiling
WO2003006687A2 (en)2001-07-102003-01-23Medigene AgNovel target genes for diseases of the heart
CA2457365A1 (en)2001-08-202003-02-27Genaissance Pharmaceuticals, Inc.Polymorphisms associated with ion-channel disease
US20030096782A1 (en)2001-09-112003-05-22The Regents Of The University Of ColoradoExpression profiling in the intact human heart
WO2003040407A2 (en)2001-11-092003-05-15Max-Planck-GesellschaftNovel markers for cardiopathies
US20070009955A1 (en)2002-07-082007-01-11Lydie BougueleretSecreted polypeptide species associated with cardiovascular disorders

Patent Citations (30)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
US20010053519A1 (en)*1990-12-062001-12-20Fodor Stephen P.A.Oligonucleotides
US5474796A (en)*1991-09-041995-12-12Protogene Laboratories, Inc.Method and apparatus for conducting an array of chemical reactions on a support surface
US20020155539A1 (en)*1999-07-282002-10-24Human Genome Sciences, Inc.Calcium channel polynucleotides, polypeptides, and antibodies
US6727063B1 (en)*1999-09-102004-04-27Millennium Pharmaceuticals, Inc.Single nucleotide polymorphisms in genes
US20030108924A1 (en)*1999-10-082003-06-12George Alfred L.Method of screening for susceptibility to drug-induced cardiac arrhythmia
US6458542B1 (en)*1999-10-082002-10-01Vanderbilt UniversityMethod of screening for susceptibility to drug-induced cardiac arrhythmia
US20020076809A1 (en)*2000-03-212002-06-20Klaus SteinmeyerPotassium channel protein KCNQ5, a new target for diseases of central nervous system and cardiovascular system
US20070026393A1 (en)*2000-04-062007-02-01Kurt BerlinDetection of variations in the dna methylation profile
US20030092019A1 (en)*2001-01-092003-05-15Millennium Pharmaceuticals, Inc.Methods and compositions for diagnosing and treating neuropsychiatric disorders such as schizophrenia
US6500630B2 (en)*2001-01-122002-12-31Mayo Foundation For Medical Education And ResearchMarker for inflammatory conditions
US20020165161A1 (en)*2001-05-042002-11-07Surromed, Inc.Chemokine-binding proteins for treating congestive heart failure
US20040029259A1 (en)*2002-04-262004-02-12Mcdevitt John T.Method and system for the detection of cardiac risk factors
US20040058388A1 (en)*2002-07-292004-03-25Hitt Ben A.Quality assurance/quality control for high throughput bioassay process
US20060147450A1 (en)*2002-10-042006-07-06Shelton David LMethods for treating cardiac arrhythmia and preventing death due to cardiac arrhythmia using ngf antagonists
US20050053956A1 (en)*2002-11-132005-03-10Dietz Harry C.Detection of a predisposition for the development of coronary artery disease
US20070141570A1 (en)*2003-03-072007-06-21Sequenom, Inc.Association of polymorphic kinase anchor proteins with cardiac phenotypes and related methods
US20070042382A1 (en)*2003-03-102007-02-22Applera CorporationGenetic polymorphisms associated with myocardial infarction, methods of detection and uses thereof
US20070038386A1 (en)*2003-08-052007-02-15Schadt Eric EComputer systems and methods for inferring casuality from cellular constituent abundance data
US20050181386A1 (en)*2003-09-232005-08-18Cornelius DiamondDiagnostic markers of cardiovascular illness and methods of use thereof
US20050142591A1 (en)*2003-10-292005-06-30Ackerman Michael J.Method of genetic testing in heritable arrhythmia syndrome patients
US20070054278A1 (en)*2003-11-182007-03-08Applera CorporationPolymorphisms in nucleic acid molecules encoding human enzyme proteins, methods of detection and uses thereof
US20050266576A1 (en)*2004-02-052005-12-01Medtronic, Inc.Identifying patients at risk for life threatening arrhythmias
US20050177196A1 (en)*2004-02-052005-08-11Orhan SoykanMethods and apparatus for identifying patients at risk for life threatening arrhythmias
US8027791B2 (en)*2004-06-232011-09-27Medtronic, Inc.Self-improving classification system
US20060024715A1 (en)*2004-07-022006-02-02Affymetrix, Inc.Methods for genotyping polymorphisms in humans
US20060063162A1 (en)*2004-09-232006-03-23Deng David XBiological marker for inflammation
US20070082347A1 (en)*2005-06-082007-04-12Myriad Genetics, IncorporatedGene variants and use thereof
US20070065865A1 (en)*2005-09-082007-03-22Affymetrix, Inc.Polymorphisms Associated with Coronary Artery Disease
US20100021903A1 (en)*2006-11-152010-01-28University Of Florida Research Foundation, Inc.Use of Genetic Determinants in Cardiovascular Risk Assessment
US20090136954A1 (en)*2007-11-142009-05-28Medtronic, Inc.Genetic markers for scd or sca therapy selection

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
Albert et al., "Prospective Study of C-Reactive Protein, Homocysteine, and Plasma Lipid Levels as Predictors of Sudden Cardiac Death", 2002, Circulation, Pages 2595-2599.*
Moss et al., "Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia", 1996, The New England Journal of Medicine, Vol. 335 Num. 26, Pages 1933-1940.*
Wright et al. ,"Proteinchip surface enhanced laser desorption/ionization (SELDI) mass spectrometry: a novel protein biochip technology for detection of prostate cancer biomarkers in complex protein mixtures", 1999, Prostate Cancer and Prostatic Diseases, Pages 264-276.*

Cited By (15)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
US20090099611A1 (en)*2006-11-302009-04-16Sigg Daniel CBiological pacemakers including mutated hyperpolarization-activated cyclic nucleotide-gated (hcn) channels
US8076305B2 (en)2006-11-302011-12-13Medtronic, Inc.Biological pacemakers including mutated hyperpolarization-activated cyclic nucleotide-gated (HCN) channels
US20110144028A1 (en)*2009-12-112011-06-16Vinod SharmaModulating cellular electrophysiology
US8639323B2 (en)2010-11-012014-01-28Medtronic, Inc.System and apparatus to monitor biopacemaker maturation
US10918853B2 (en)2013-05-302021-02-16Neurostim Solutions, LlcTopical neurological stimulation
US10307591B2 (en)2013-05-302019-06-04Neurostim Solutions, LlcTopical neurological stimulation
US10016600B2 (en)2013-05-302018-07-10Neurostim Solutions, LlcTopical neurological stimulation
US10946185B2 (en)2013-05-302021-03-16Neurostim Solutions, LlcTopical neurological stimulation
US11229789B2 (en)2013-05-302022-01-25Neurostim Oab, Inc.Neuro activator with controller
US11291828B2 (en)2013-05-302022-04-05Neurostim Solutions LLCTopical neurological stimulation
US11312994B2 (en)2014-05-052022-04-26Medtronic, IncMethods and compositions for SCD, CRT, CRT-D, or SCA therapy identification and/or selection
US11077301B2 (en)2015-02-212021-08-03NeurostimOAB, Inc.Topical nerve stimulator and sensor for bladder control
US10953225B2 (en)2017-11-072021-03-23Neurostim Oab, Inc.Non-invasive nerve activator with adaptive circuit
US11458311B2 (en)2019-06-262022-10-04Neurostim Technologies LlcNon-invasive nerve activator patch with adaptive circuit
US11730958B2 (en)2019-12-162023-08-22Neurostim Solutions, LlcNon-invasive nerve activator with boosted charge delivery

Also Published As

Publication numberPublication date
US20050266576A1 (en)2005-12-01
US7608458B2 (en)2009-10-27

Similar Documents

PublicationPublication DateTitle
US7608458B2 (en)Identifying patients at risk for life threatening arrhythmias
US7622303B2 (en)Methods for identifying patients at risk for life threatening arrhythmias
US8027791B2 (en)Self-improving classification system
US8335652B2 (en)Self-improving identification method
US11307208B2 (en)Biomarkers for cognitive impairment and methods for detecting cognitive impairment using such biomarkers
US20030013120A1 (en)System and method for differential protein expression and a diagnostic biomarker discovery system and method using same
EP2470911B1 (en)Galectin-3 and cardiac resynchronization therapy
EP3178846B1 (en)Novel phosphorylation of cardiac troponin i as a monitor for cardiac injury
EP2386969A2 (en)Self-improving classification system
US8206986B2 (en)Methods for detecting Alzheimer's disease
EP3654038B1 (en)Biomarker for cognitive impairment disorders and detection method for cognitive impairment disorders using said biomarker
US20050106104A1 (en)Methods for diagnosing cardiovascular disorders
DaubenspeckProteomic Analysis of Ischemic Stroke Blood Biomarkers
Guerreiro et al.Proteomic profiling of cerebrospinal fluid by 8-plex iTRAQ reveals potential biomarker candidates of Alzheimer’s disease

Legal Events

DateCodeTitleDescription
STCBInformation on status: application discontinuation

Free format text:ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION


[8]ページ先頭

©2009-2025 Movatter.jp